Ischemic cardiomyopathy changes how the heart pumps blood because of muscle damage. Learn about the role of medication in ...

Through it all — the dilated cardiomyopathy diagnosis, the heart transplant, the recovery — Jabri Fox, now 12, has tried to ...

Reached alignment with FDA on key elements of registrational development plan for LX2006, including accelerated approval pathway with ...

Analysing Cytokinetics' potential in the biopharma market with its drug aficamten, projected peak sales of $3.6 billion and ...

Two years after undergoing a heart transplant, 12-year-old Jabri Fox says she's a changed person, cognizant that life is full ...

BACKGROUND: The ability to predict recovery of left ventricular ejection fraction (LVEF) in response to guideline-directed therapy among patients with nonischemic cardiomyopathy is desired. We sought ...

Linda Marban; President, Chief Executive Officer, Director; Capricor Therapeutics Inc ...

In a report released today, Mitchell Kapoor from H.C. Wainwright reiterated a Buy rating on Lexeo Therapeutics, Inc. (LXEO – Research ...

Implantation of the Ventura interatrial shunt, while safe, does not improve clinical outcomes or prognosis in patients with HF and preserved LVEF.

The primary endpoints are the change from baseline in mNIS+7 ... Simultaneously, the rapid enrollment of the MAGNITUDE trial ...

Received IND clearance from the U.S. FDA to initiate MAGNITUDE-2 Phase 3 trial of nexiguran ziclumeran (nex-z) in patients ...

Cardiomyopathy can cause irregular heartbeats ... has been diagnosed with an inherited heart disease, talk with your primary care doctor or a cardiologist. Your physician will typically recommend ...